Bepranemab (UCB0107)
| Disease area studied | Abbreviated title | Phase | Study ID | Registry database | Study results | Plain language summary | Publication (if available) |
|---|---|---|---|---|---|---|---|
| Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) | A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD) | Phase 2 |
AH0003
Ongoing |
NCT04867616 2020-005829-88 2023-506170-12-00 |
|||
| Progressive Supranuclear Palsy | A Study to Test the Safety and Tolerability of Long-term UCB0107 Administration in Study Participants With Progressive Supranuclear Palsy | Phase 1 |
PSP002
Ongoing |
NCT04658199 2024-510951-36-00 |